Researchers at Medtronic are developing a prototype neural implant that uses light to alter the behavior of neurons in the brain.

The device is based on the emerging science of optogenetic neuromodulation, in which specific brain cells are genetically engineered to respond to light.

The company plans to market the device to neuroscience researchers and use it for in-house research on the effects of DBS.